Access to the information available in the following pages may be restricted in certain countries by applicable laws and regulations. Persons who are physically located in those jurisdictions and who would like to access the information available in the following pages must inform themselves about and observe such restrictions.
The information available in the following pages may be freely accessed by French residents who are physically located in France.
With respect to each Member State of the European Economic Area other than France (the “Relevant Member States” and individually, a “Relevant Member State”) and the United Kingdom which are subject to the provisions of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017, as amended (the “Prospectus Regulation”) as it also forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (the “EUWA”), the information available in the following pages is directed only at any legal entity which is a qualified investor as defined in the Prospectus Regulation, as it also forms part of domestic law of the United Kingdom by virtue of the EUWA. These restrictions with respect to any Relevant Member State or the United Kingdom apply in addition to any other restrictions which may be applicable in any Relevant Member State or the United Kingdom.
This website and the information contained herein are not intended for, and may not be accessed by, or distributed or disseminated to, persons resident or physically present in the United States of America (including its territories, the “United States”), Canada, Japan or Australia, and do not constitute, and shall not be construed as, an offer to sell or a solicitation of an offer to purchase or acquire, directly or indirectly, any shares or other securities of Clariane in the United States, Canada, Japan or Australia or to, or for the account or benefit of, any person resident in the United States, Japan, Canada, Australia including any corporation or other entity organized under the laws of the United States, Japan, Canada or Australia. The shares or other securities of Clariane referred to on this website have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), and may not be offered or sold in the United States absent registration under or pursuant to an exemption from, or in a transaction not subject to, the registration under the U.S. Securities Act.
All persons residing outside of France and outside of the United States, Canada, Japan and Australia who wish to access the documents contained on this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website, or require registration or approval for any acquisition of securities by them. No such registration or approval has been obtained. Clariane assumes no responsibility if there is a violation of applicable law and regulations by any person.
By accessing to the information available in the following pages, you confirm that you are in compliance, and agree to comply, with the restrictions described above.
I therefore certify that:
- I am a resident of and physically present in France;
or
- I am a resident of and physically present in a Member State of the European Economic Area (other than France) or the United Kingdom, and I am either:
- a qualified investor as defined in the Prospectus Regulation, as it also forms part of domestic law of the United Kingdom by virtue of the EUWA,
ou
- otherwise authorized to access this information pursuant to applicable laws or regulations;
et
- I am not a resident of or physically present in the United States, Canada, Japan or Australia.
I have read and understand the foregoing, and hereby make the certifications above and agree to comply with all of the above restrictions.
The information contained herein is exclusively intended for (i) persons resident of and physically present in France and (ii) persons resident of and physically present in other Member States of the European Union or in the United Kingdom and being qualified investors within the meaning of the Regulation (EU) 2017/1129, as it also forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018. It does not constitute an offer to sell securities in any other country. The securities of Clariane may not be offered or sold in Canada, Japan or Australia. Furthermore, no securities may be offered or sold in the United States absent registration with the Securities and Exchange Commission under the U.S. Securities Act of 1933 as amended, or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act of 1933, as amended. Clariane has no intention to register the transaction in the United States or to make a public offering of its securities in the United States.
